Stryker Corporation $SYK is CWS Financial Advisors LLC’s Largest Position

CWS Financial Advisors LLC cut its position in Stryker Corporation (NYSE:SYK) by 0.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 252,176 shares of the medical technology company’s stock after selling 1,974 shares during the quarter. Stryker accounts for 24.1% of CWS Financial Advisors LLC’s holdings, making the stock its largest holding. CWS Financial Advisors LLC owned approximately 0.07% of Stryker worth $88,632,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of SYK. Corient Private Wealth LLC lifted its stake in Stryker by 104.4% during the 2nd quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock worth $887,525,000 after acquiring an additional 1,146,998 shares in the last quarter. Alliancebernstein L.P. lifted its stake in Stryker by 13.3% during the 3rd quarter. Alliancebernstein L.P. now owns 6,338,050 shares of the medical technology company’s stock worth $2,342,987,000 after acquiring an additional 741,542 shares in the last quarter. Strive Asset Management LLC acquired a new position in Stryker during the 3rd quarter worth about $227,389,000. Credit Agricole S A purchased a new position in shares of Stryker in the third quarter valued at approximately $194,045,000. Finally, Pictet Asset Management Holding SA boosted its stake in shares of Stryker by 190.3% in the fourth quarter. Pictet Asset Management Holding SA now owns 466,256 shares of the medical technology company’s stock valued at $163,878,000 after purchasing an additional 305,640 shares during the period. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Transactions at Stryker

In related news, VP M Kathryn Fink sold 5,220 shares of Stryker stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $283.85, for a total value of $1,481,697.00. Following the completion of the transaction, the vice president owned 13,137 shares in the company, valued at $3,728,937.45. The trade was a 28.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.60% of the stock is owned by corporate insiders.

Stryker Stock Up 1.0%

Shares of Stryker stock opened at $320.99 on Thursday. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $404.87. The company has a 50 day moving average of $326.71 and a 200 day moving average of $350.36. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $123.06 billion, a P/E ratio of 37.15, a P/E/G ratio of 2.00 and a beta of 0.80.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $6.34 billion. During the same quarter in the prior year, the firm earned $2.84 EPS. The firm’s revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, research analysts forecast that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a $0.88 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s payout ratio is currently 40.74%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on SYK shares. Leerink Partners started coverage on shares of Stryker in a research note on Monday, April 13th. They issued an “outperform” rating and a $410.00 price objective for the company. The Goldman Sachs Group reissued a “neutral” rating and issued a $361.00 price objective on shares of Stryker in a research note on Friday, May 1st. Wall Street Zen lowered shares of Stryker from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Truist Financial reissued a “hold” rating and issued a $330.00 price objective (down from $380.00) on shares of Stryker in a research note on Monday, May 4th. Finally, TD Cowen lowered shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price objective for the company. in a research note on Monday, January 26th. Sixteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $395.48.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.